A review of prognostic molecular biomarkers for glioblastoma and their clinical significance for diagnosis and treatment
Glioblastoma (GBM) is a WHO grade IV malignant brain tumor with a poor prognosis, and it is the most common primary malignant brain tumor in adults. The estimated overall survival rate for patients with GBM is less than 1.5 years, with a 5-year survival rate of about 5 %. Current treatment standards...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
NAMS of Ukraine, State Organization "Scientific-Practical Center of Endovascular Neuroradiology, Non-Governmental Organization “All Ukrainian Association of Endovascular Neuroradiology, Shupyk National Healthcare University of Ukraine
2024-10-01
|
| Series: | Українська Інтервенційна Нейрорадіологія та Хірургія |
| Subjects: | |
| Online Access: | https://enj.org.ua/index.php/journal/article/view/278 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|